Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma by Speijer, H. (H.) et al.
Atherosclerosis, 90 (1991) 159-168 




Different locations of cholesteryl ester transfer protein 
and phospholipid transfer protein activities in plasma 
H. Speijer, J.E.M. Groener *, E. van Ramshorst and A. van To1 
Department of Biochemistry, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Rotterdam (The Netherlands) 
(Received 20 March, 1991) 
(Revised, received 1 July, 1991) 
(Accepted 8 July, 1991) 
Summary 
Activities of cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP) were 
measured in plasma of four vertebrate species: man, rabbit, pig, and rat. The activities were measured in 
the absence and presence of antibodies raised against purified human CETP. PLTP activities were 
present in all four species with highest values in pig (11.7 + 1.2 U/ml> and human plasma (9.2 f 1.6 
U/ml). Considerable lower activities were found in rabbit (3.5 of: 0.6 U/ml) and rat plasma (1.6 + 0.7 
U/ml>. These activities were not affected significantly by antibody against human CETP. CETP activities 
could be measured in human (0.23 f 0.05 U/ml> and in rabbit plasma (0.19 + 0.03 U/ml). CETP activity 
in human plasma was inhibited over 97% by antibody against human CETP. Plasma was chro- 
matographed on a Superose 6 gel filtration column. Average HDL particle sizes in the four species 
differed notably and decreased in the order: rat HDL > rabbit HDL > human HDL > pig HDL. A 
separation of the two lipid transfer activities was evident after gel filtration chromatography. The peak of 
the PLTP activity coeluted with a fraction of HDL particles with the size of human HDL, (particle 
weights 300-375 kDa). CETP activity in human and rabbit plasma coeluted largely with relatively small 
HDL particles (particle weights 140-180 kDa). These results show that CETP and PLTP activities are 
located in different macromolecular complexes. 
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Introduction Methods 
Plasma lipid transfer proteins have an impor- 
tant influence on lipoprotein composition and 
lipid metabolism [1,2]. The activity of these pro- 
teins may be related to atherogenesis. At least 
two plasma lipid transfer proteins have been rec- 
ognized [3-61. Most knowledge exists about the 
cholesteryl ester transfer protein (CETP or LTP-I) 
which transfers cholesteryl esters, triglycerides, 
and phospholipids between lipoproteins. The gene 
for this protein has been cloned and sequenced 
and codes for a highly hydrophobic protein [7]. 
Apparent molecular weigh& of the protein on 
SDS gels of 64-74 kDa have been reported 
[4,6,8,9]. Studies with monoclonal antibodies sug- 
gest that this protein is responsible for all 
cholesteryl ester transfer activity in plasma [lo]. 
Less is known about another plasma lipid 
transfer protein, the phospholipid transfer pro- 
tein (PLTP or LTP-II), which enhances transfer 
of phospholipids between lipoproteins [11,121 or 
between phospholipid vesicles and HDL [13,14]. 
Some studies on its purification have appeared, 
but different molecular weights of 41 kDa [51 and 
69 kDa [12] are reported. 
In whole plasma the lipid transfer proteins 
may be compltixed with lipoproteins. CETP is 
associated with a small-sized HDL subfraction 
after gel filtration chromatography of fasting 
plasma [15-171. Also, electrophoretic and im- 
munological methods have shown that CETP is 
located in apo A-I-containing lipoproteins [18- 
201. Localization studies of PLTP are not avail- 
able. However, ultracentrifugation experiments 
have shown that PLTP is found in a HDL frac- 
tion with very high density (1.20-1.26 g/ml> [13]. 
There is a considerable variation in the activity 
of CETP between species [21]. The activity of 
PLTP in different species is not well documented. 
In this report we present the activities of both 
proteins in human, rabbit, pig, and rat plasma 
measured in the absence, and in the presence of 
antibodies directed to human CETP. Further- 
more, cholesteryl ester and phospholipid transfer 
activity profiles after gel filtration of plasma are 
presented. 
Ma teriaks 
Egg phosphatidylcholine (type III E), buty- 
lated hydroxy toluene and 5,5-dithiobis(2-nitro- 
benzoic acid) were obtained from Sigma (St. 
Louis, MO, U.S.A.). Cholesteryl [ l-‘4C]oleate 
(spec. act., 57 Ci/mol) was from NEN Research 
Products, E.I. du Pont de Nemours and Co. (Inc.), 
U.S.A. L-3-Phosphatidyl [N-methyl- 3H]choline, 
1,2-dipalmitoyl (spec. act., 76 Ci/mmol) was from 
Amersham International plc (Amersham, U.K.). 
Intralipid (10%) was purchased from Kabi Vit- 
rum (Stockholm, Sweden). Heparin (thrombo- 
liquine, 5000 U/ml> was from Organon Teknika 
(Boxtel, The Netherlands). Dextran sulphate, 
phenyl-Sepharose, CNBr-activated Sepharose, 
Sepharose CL-4B, Superose 6 prep-grade and 
Mono-Q HR 5/5 column were purchased from 
Pharmacia (Uppsala, Sweden). CM-cellulose 52 
was from Whatman Ltd. (Maidstone, U.K.). Hep- 
arin-Sepharose was prepared by coupling heparin 
to CNBr-activated Sepharose according to the 
manufacturers instructions (Pharmacia). Fasted 
plasma from human volunteers (age 32 + 6 year), 
from Wistar rats (weighing 320 * 20 g), from New 
Zealand white rabbits (weighing 2.7 f 0.2 kg), 
and from Yorkshire pigs (weighing 61 5 6 kg) was 
used. 
Purification of human CETP 
CETP was partially purified from the d > 1.18 
g/ml fraction of human plasma by the method 
described by Morton and Zilversmit [3], using 
phenyl-Sepharose and CM-cellulose chromatog- 
raphy. The resulting CETP fraction was dialysed 
against 10 mM Tris-HCl, containing 50 mM NaCl 
and 1 mM EDTA (pH 7.4), and was chro- 
matographed on a heparin-Sepharose column 
(1.3 x 29 cm), equilibrated with the same buffer, 
in order to remove the phospholipid transfer pro- 
tein, which binds to the column [4,14], while most 
other proteins, including CETP, do not bind un- 
der these conditions. The unbound fraction was 
dialysed against 25 mM Tris-HCl, containing‘ 1 
mM EDTA (pH 7.4) and was further purified by 
anion exchange chromatography. Up to 15 mg 
protein was applied to a Mono-Q HR 5/5 col- 
umn, equilibrated with 25 mM Tris-HCl, 1 mM 
EDTA (pH 7.41, and eluted with a gradient from 
0 to 400 mM NaCl in the same buffer. The flow 
rate was 2 ml/min. When applied to a freshly 
washed column, CETP activity elutes in a sharp 
peak at about 80 mM NaCI, while the bulk of 
proteins elute at higher salt concentrations. The 
fraction containing CETP activity was concen- 
trated by spindialysis using the Centricon 10 mi- 
croconcentrator (Amicon, Danvers, MA, U.S.A.) 
to 5-10 mg protein per ml and further purified by 
binding of CETP to an artificial triglyceride/ 
phospholipid emulsion (Intralipid, cf. Ref. 6). In- 
tralipid was purified before use. 3 ml Intralipid 
solution, containing 5% sucrose, was layered un- 
der 9 ml 0.5 mM EDTA (pH 7.4) solution in a 
SW40 tube, and centrifuged for 15 min at 28000 
rpm and 0-5°C. The lipid cake was sliced off and 
resuspended in about 1 ml 0.5 mM EDTA (pH 
7.4) solution and immediately used for further 
experiments. The emulsion was incubated under 
N, with concentrated Mono-Q fraction (45 mg 
triglycerides/mg protein) in 150 mM NaCl, con- 
taining 20 mM Tris-HCl, 20 mM dithiothreitol, 
0.5 mM EDTA (pH 7.41, for 15 min at 37°C. 
After incubation, the mixture was put on ice and 
subsequently chromatographed on a Sepharose 
CL4B column (2.5 X 40 cm) equilibrated with 50 
mM NH,HCO,, containing 0.5 mM EDTA (pH 
8.01, at a flow of 50 ml/h. Void volume fractions, 
containing the lipid emulsion and bound CETP 
activity, were lyophilized and delipidated by ex- 
traction with ethanol/ether (v/v, 3 : 2), as de- 
scribed by Hesler et al. 161. The delipidated mate- 
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rial was dissolved in H,O to a protein concentra- 
tion of 0.1 mg/ml and assayed for CETP activity. 
SDS-PAGE in the presence of mercaptoethanol 
showed one band with a molecular weight of 66 
kDa on staining with Coomassie brilliant blue. 
Table 1 shows a summary of the purification of 
human CETP. 
Preparation of antibody to CETP 
Antibodies were raised in a chicken. 50 pg 
purified human CETP were injected intramuscu- 
larly into the thigh at two sites, followed by 2 
booster injections of 50 pg protein at 3-week 
intervals. A pre-immune-serum and antisera at 
several points of time were collected and tested 
for inhibition of CETP activity. IgG were isolated 
from the chickens eggs, according to the method 
of Jensenius et al. [22]. In short, egg yolks were 
diluted with 140 mM NaCl, containing 10 mM 
Tris-HCl, 0.1% NaN, (pH 7.41, and yolk lipid/ 
protein complexes were precipitated with dextran 
sulphate/CaCl 2. The lipids were subsequently 
removed by centrifugation. The IgG present in 
the supernatant were then precipitated by addi- 
tion of sodium-sulphate. The precipitate was dis- 
solved and dialysed against buffered saline (see 
above) and stored at 4°C. 
Isolation of lipoproteins and radiolabelling of LDL 
Isolation of HDL,, HDL, LDL, and VLDL 
was performed according to Have1 et al. [23]. 
LDL was labelled with cholesteryl [l-‘4C]oleate 
by the method of Morton and Zilversmit [24]. 
Reisolation of LDL was done as described by 
Groener et al. [25]. 
TABLE 1 
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Aksay of cholesteryl ester transfer protein activity 
Cholesteryl ester transfer protein (CETP) ac- 
tivity in plasma and column fractions was mea- 
sured by exchange of radiolabelled cholestetyl 
oleate between exogenous LDL and HDL and 
was performed as described [25] with the follow- 
ing modifications: VLDL and LDL from plasma 
samples were precipitated with phospho- 
tungstate/Mg2+ [26] instead of polyethylenegly- 
col, and the supernatant was used as source for 
CETP. After 16 h the incubation was stopped by 
cooling on ice and subsequently LDL was precipi- 
tated with 300 ~1 0.1 M sodium-phosphate (pH 
7.4) and 167 ~1 of a 0.1 M-MnCl, solution [151, 
followed by centrifugation (30 min, 1500 X g> to 
remove the precipitate. Radioactivity in HDL was 
measured by liquid scintillation counting. Activity 
is expressed in U/ml, i.e. pmol cholesteryl ester 
exchanged/h/ml. 
Assay of phospholipid transfer protein activity 
Phospholipid transfer protein (PLTP) activity 
was measured in a phospholipid vesicles-HDL 
assay system. This assay is specific for PLTP 
aetivity, since CETP, which does promote ex- 
change of phospholipids between lipoproteins, 
shows no significant activity in this system under 
the conditions used [5] (see also Results and 
Discussion). Radiolabelled vesicles were pre- 
pared by mixing 10 pmoles egg phosphatidyl- 
choline with 1 PCi of [3H]phosphatidylcholine 
and 0.1 pmol butylated hydroxytoluene. The 
lipids were dried under N, and 1 ml 150 mM 
NaCl, containing 10 mM Tris-HCl and 1 mM 
EDTA (pH 7.4), was added. The lipids were 
dispersed by sonicating three times for 5 min on 
ice with a probe type sonifier. Measurement of 
facilitated transfer of phosphatidylcholine from 
vesicles to HDL was determined essentially by 
the method described by Damen et al. [14]. In 
short, plasma samples or column fractions were 
incubated with vesicles and HDL for 1.5 h at 
37°C. The reaction was stopped on ice and the 
vesicles were precipitated by adding 320 mM 
NaCI, 92 mM MnCl, and 200 U/ml heparin 
(final concentrations). The precipitate was re- 
moved by centrifugation and radioactivity was 
determined in the supernatant by liquid scintilla- 
tion counting. Activity is expressed in U/ml (1 
unit is defined as 1 pmol phospholipid trans- 
ferred/h) and is corrected for spontaneous trans- 
fer at 37°C. Sample amounts were chosen such 
that phospholipid transfer remained in the linear 
range with respect to incubation time and sample 
volume. The transfer of radioactive phospholipid 
during the 1.5 h incubation was less than 20% of 
total vesicle radioactivity. 
Gel filtration of fasting plasma 
Plasma from 2 subjects of each of the 4 species 
was chromatographed on a Superose 6 prep grade 
column (100 ml, Pharmacia) according to Van 
Gent and Van To1 [17]. 2 ml plasma was used, the 
flow rate was 0.25 ml/min, and 2.73-ml fractions 
were collected. The elution buffer was 150 mM 
NaCl, containing 2 mM sodium phosphate, 5 mM 
EDTA and 0.02% NaN, (pH 7.4). Each fraction 
was tested for CETP activity, PLTP activity, total 
cholesterol and total triglycerides. Recoveries of 
CETP activity (n = 4), PLTP activity (n = 6) total 
cholesterol (n = 6), and triglycerides (n = 6) were 
76+7%, 85f 14%, 99+9% and 76+8%, re- 
spectively. 
Other methods 
Total cholesterol and triglycerides were mea- 
sured enzymatically using commercially available 
kits (Boehringer Mannheim, F.R.G., kit no. 
310328 plus cholesterol esterase, and kit no. 
877557, resp.). Protein concentrations were deter- 
mined by the method of Lowry et al. [27] or 
Sedmak and Grossberg [28] with bovine serum 
albumin as a standard. SDS-PAGE was per- 
formed according to Laemmli [291. 
Results 
Lipid transfer activities in different species 
Total cholesterol, triglycerides, and the activi- 
ties of two distinct lipid transfer proteins (CETP 
and PLTP) were measured in plasma of four 
different species: man, rabbit, pig, and rat. Table 
2 shows a summary of the results of these mea- 
surements. Both human and rabbit plasma have 
relatively high CETP activity, while the activities 
in pig and rat plasma are undetectable. PLTP 
activity is present in all four species tested, al- 
though plasma activity levels differ markedly. The 
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TABLE 2 
CETP AND PLTP ACTIVITIES, TOTAL CHOLESTEROL, TRIGLYCERIDES, IN HUMAN, RABBIT. PIG, AND RAT 
PLASMA 
Human (n = 61 Rabbit (n = 71 Pig (n = 7) Rat (n = 61 
CETP 0.225 f 0.046 0.192 + 0.029 0.002 + 0.002 0.002 + 0.001 
PLTP 9.2 k 1.6 3.5 +0.6 11.7 +1.2 1.6 kO.7 
TC 4.89 kO.95 1.42 kO.65 1.95 kO.33 1.64 kO.10 
TG 0.97 kO.36 0.42 +O.lO 0.49 kO.12 0.74 io.11 
CETP activity was measured in 10 ~1 plasma and is expressed in U/ml. PLTP activity was measured in 5 ~1 plasma samples, ten 
times diluted in 150 mM NaCl, containing 10 mM sodium phosphate, 1 mM EDTA and 0.01% NaN, (pH 7.41, and is expressed in 
U/ml. Total cholesterol (TC) and triglycerides (TG) were determined enzymatically and are given in mM. 
activity of PLTP was highest in pig and human 
plasma, and much lower in rabbit and rat plasma. 
Inhibition studies with antibodies to CETP 
CETP was isolated from human plasma by 
several sequential purification steps. The final 
preparation showed one band on SDS-PAGE with 
an apparent molecular weight of 66000 and was 
used to immunize a chicken. Antibodies were 
detectable both in the serum and in the egg yolk 
of the chicken by immunoprecipitation and activ- 
ity measurements. IgG isolated from the egg yolk 
were tested for the ability to inhibit CETP. In- 





3 10 I I 30 I 100 300 
ug m 
Fig. 1. Inhibition of CETP activity by anti-human CETP IgG. 
Samples (15 ~1) of a human serum pool were assayed for 
CETP activity in the presence of varying amounts of anti-hu- 
man CETP egg IgG (A - a), or non-immune egg IgG 
(o- 0). CETP activity is expressed as percentage of 
control activity (no antibody). This is a representative experi- 
ment from a series of 2, using two different IgG preparations. 
The effects of non-immune IgG are considered insignificant. 
creasing amounts of egg IgG were incubated with 
15 ~1 of a human serum pool and the remaining 
CETP activity was measured (Fig. 1). CETP was 
inhibited over 97% in the presence of 70 Fg 
anti-human CETP IgG. Subsequently, we assayed 
CETP and PLTP activity in human, rabbit and 
pig plasma and determined the effect of anti-hu- 
man CETP IgG on these activities, using non-im- 
mune egg IgG as control. Part of the results are 
shown in Table 3. The CETP activities in the 
three human plasma samples were reduced by 
97% or more when incubated with anti-human 
CETP IgG. PLTP activities in these plasmas were 
however unaffected by the antibodies. Rabbit 
CETP activity is inhibited by about 23% using the 
same conditions (not shown). Rabbit and pig 
plasma PLTP activities appeared to be unaffected 
by the presence of anti-human CETP IgG. 
TABLE 3 
INHIBITION OF CETP AND PLTP ACTIVITIES IN HU- 
MAN PLASMA BY ANTI-HUMAN CETP 1gG 
Expt. I Expt. II 
(remaining activities) 
Expt. III 
human CETP 2% 3% 2% 
human PLTP 89% 105% 100% 
Activities are presented as % of the original activity. CETP 
activity was measured in 15 gl plasma in the presence of 76 
pg anti-human CETP egg IgG or non-immune egg IgG. PLTP 
activity in 5 ~1 plasma samples, diluted 10 times in 150 mM 
NaCI, containing 10 mM sodium phosphate, 1 mM EDTA, 
and 0.01% NaN, (pH 7.41, was measured in the presence of 3 
pg anti-human CETP egg IgG or non-immune egg IgG. 
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Localisation of transfer protein activities as deter- 
mined by gel filtration of plasma 
In order to examine with which lipoprotein 
fraction CETP and PLTP are associated, plasma 
was fractionated by gel filtration chromatography. 
Plasma samples from two subjects of each of the 
four species were chromatographed as described 
in Methods. All fractions were tested for total 
cholesterol and triglyceride content as well as 
CETP and PLTP activities. The column profiles 
obtained in this way from one individual of each 
species are shown in Figs. 2 and 3. Both individ- 
ual plasma samples gave essentially the same 
results. Upon measurement of the lipids in the 
column fractions. the elution profiles show three 
FRACTION lylyBER 
lipoprotein peaks (Figs. 2 and 3, A and C) with 
the exception of rat plasma, which shows only two 
(cf. Refs. [30-321). The first peak, present in the 
void volume, contains VLDL, consistent with its 
relatively high triglyceride and low cholesterol 
content. The second peak corresponds with LDL 
and the third peak with HDL particles. By con- 
trast, the second peak in rat plasma corresponds 
with HDL (with a small contribution of LDL and 
a substantial contribution of the large HDL,). 
LDL from human as well as rabbit plasma are 
mostly recovered in column fractions 10 and 11. 
Therefore the LDL in human and rabbit plasma 
are of comparable size. Pig LDL tend to be 
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Fig. 2. Gelfiltration chromatography of human and rabbit plasma. Samples (2 ml) of human (A, B) and rabbit (C, D) plasma were 
chromatographed on a Superose 6 column. Column fractions were assayed for total cholesterol (A - A) and triglyceride 
(O- O) content. Lipid contents of the fractions are given in nmol/ml of injected plasma (summation of all fractions results in 
total plasma concentration in nmoles/ml). Aliquots of 100 ~1 and 5 ~1 were taken and assayed for CETP (0 - ??) and PLTP 
(a- 0) activity, respectively. Activities in the fractions are expressed in nmol/ml injected plasma/h (CETP) or nmol/ml 
injected plasma/min (PLTP). The three vertical lines from left to right represent the peak elution volumes of isolated human 
VLDL, LDL and HDL, respectively. The column was further calibrated as described in [17]. 
FRACTION MAIBER 
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Fig. 3. Gel filtration chromatography of pig (A, B) and rat (C, D) plasma. For further details see the legend to Fig 2. 
the different mammals are clearly different. As 
mentioned above, rat HDL have the biggest aver- 
age size, due to the large amounts of big, apo 
E-rich HDL in plasma from this species. The 
average size of HDL from rabbit plasma is also 
bigger than human HDL, while HDL from pig 
plasma, just like pig LDL, are smaller than the 
human counterpart. 
From the lipid transfer activity patterns (Figs. 
2 and 3, B and D) it is apparent that CETP 
activity in human and rabbit plasma coelutes with 
a subfraction of relatively small HDL particles 
and may elute to some extent as free protein 
molecules. The CETP activity peak elutes at an 
apparent molecular weight of about 160 kDa. 
PLTP activity also coelutes with HDL, but mainly 
with a subfraction of a relatively large size. In 
human and pig plasma highest activity elutes at 
an apparent molecular weight of about 300 kDa, 
while in rat and rabbit plasma a larger apparent 
molecular weight of about 375 kDa is observed. 
Taken together, it is clear that PLTP and CETP 
activities elute in different fractions. 
Discussion 
The existence of two separate plasma lipid 
transfer proteins (CETP and PLTP) has been 
described [4,5]. Apart from its activity in human 
plasma, PLTP activity has also been reported for 
rat plasma [11,33]. In the present study we have 
shown that, in addition to human and rat plasma, 
plasma from rabbits and pigs also contains PLTP 
activity, although the activities differ markedly 
between species. 
The CETP activities in human and rabbit 
plasma were found to be of the same order of 
magnitude. This was surprising as literature [21] 
indicates a higher level in the rabbit. However it 
was also shown that rabbit plasma CETP activity 
is very sensitive to dietary conditions [34]. Also 
the use of rabbits with different genetic back- 
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grounds could be responsible for the apparent 
discrepancy. In our study, in accordance with 
published data [21], we could not detect apprecia- 
ble CETP activity in pig and rat plasma. Whether 
this is a consequence of low rates of synthesis and 
secretion of CETP protein, or the result of the 
presence of an inhibitor protein in plasma, is not 
yet clear. Nagashima et al. [35] reported signifi- 
cant amounts of CETP mRNA in human, rhesus, 
and rabbit liver, but very low or undetectable 
levels in pig, rat, and mouse liver. However, other 
investigators have reported that muscle, heart 
and adipose tissue of rats and mice also contain 
CETP-like mRNA species [36]. The presence of 
an inhibitor protein in human, pig, and rat plasma 
could mask the activity of CETP in pig and rat 
plasma [37,38]. 
Experiments with a polyclonal antibody prepa- 
ration against human CETP show that CETP 
activity in a human plasma sample is almost com- 
pletely inhibited. Using the same antibodies, 
CETP activity in rabbit plasma is inhibited by 
about 23% under the conditions used. This is 
probably caused by crossreactivity between rabbit 
CETP and the anti-human CETP IgG. Some 
crossreactivity is not surprising since the amino 
acid sequence of rabbit CETP, obtained from a 
cDNA sequence, shows 81% homology with hu- 
man CETP [35]. 
Facilitated phospholipid transfer between 
phospholipid vesicles and HDL, by any of the 
plasma samples tested, is not inhibited signifi- 
cantly by anti-human CETP IgG. It can be con- 
cluded that phospholipid transfer activity in hu- 
man plasma measured with this assay mainly re- 
sults from the activity of PLTP. 
The gel filtration experiments also show that 
the two lipid transfer activities are mediated by 
different proteins. In both human and rabbit 
plasma, PLTP activity is separated from CETP 
transfer activity. CETP coelutes with the trailing 
edge of the HDL peak, suggesting its association 
with small HDL particles. In all experiments per- 
formed the complex has a particle weight be- 
tween 140 and 180 kDa. In contrast, PLTP elutes 
in the front of the HDL peak, suggesting a com- 
plex of relatively large size with particle weights 
ranging from about 300 kDa in human and pig 
plasma to about 375 kDa in rat and rabbit plasma. 
This apparently is in contrast to results of ultra- 
centrifugation experiments, where PLTP was 
found in the smaller, denser HDL subclasses, 
together with CETP [13]. However, results ob- 
tained by ultracentrifugation may not represent 
the situation in whole plasma, since, after pro- 
longed ultracentrifugation, both proteins are re- 
covered in the lipoprotein free fraction due to 
dissociation from the lipoprotein particles [13,15]. 
The average HDL sizes in the various species 
differ markedly. It was published recently that 
the size of HDL is increased in patients with 
CETP deficiency [39]. This big HDL is also en- 
riched in apo E and resembles HDL from rat, a 
species with very low plasma CETP activity. The 
authors hypothesized that HDL size may be 
strongly related to plasma CETP activity levels. 
From our present data it is clear, however, that 
the situation is more complicated. The results 
obtained in pig plasma, with relatively small HDL 
in combination with virtually zero CETP activity, 
show that CETP activity may not be the most 
important factor determining HDL size. We re- 
cently described a new lipid transfer reaction in 
human plasma, resulting in net mass transfer of 
cholesteryl ester from LDL to HDL [40]. This 
reaction contributes to an increase in the size of 
HDL, opposing the known effects of CETP. 
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